Prostate Cancer: A Contemporary Approach to Treatment and Outcomes
- PMID: 29406054
- DOI: 10.1016/j.mcna.2017.10.001
Prostate Cancer: A Contemporary Approach to Treatment and Outcomes
Abstract
Given the high incidence of prostate cancer and the need for shared decision-making before screening, it is imperative that primary care providers understand treatment options and treatment adverse effects. In this review article, the treatment options for the localized and metastatic prostate cancer are discussed, including the different modalities and their indications, adverse effects, oncologic outcomes, posttreatment monitoring, and potential treatment options following cancer recurrence.
Keywords: Operative; Prostatic neoplasm; Radiotherapy; Surgical procedures; Therapeutics; Treatment outcomes; Watchful waiting.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Decision-Making in Prostate Cancer: Active Surveillance Over Other Treatment Options.Urol Nurs. 2016 May-Jun;36(3):141-9. Urol Nurs. 2016. PMID: 27501595
-
Understanding Medical Decision-making in Prostate Cancer Care.Am J Mens Health. 2018 Sep;12(5):1635-1647. doi: 10.1177/1557988318780851. Epub 2018 Jun 7. Am J Mens Health. 2018. PMID: 29877127 Free PMC article.
-
Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.Urol Nurs. 2017 Jan-Feb;37(1):15-22. Urol Nurs. 2017. PMID: 29240360 Review.
-
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.Eur Urol Oncol. 2018 May;1(1):37-45. doi: 10.1016/j.euo.2018.02.003. Epub 2018 May 15. Eur Urol Oncol. 2018. PMID: 31100227
-
Expectant management for men with early stage prostate cancer.CA Cancer J Clin. 2015 Jul-Aug;65(4):265-82. doi: 10.3322/caac.21278. Epub 2015 May 8. CA Cancer J Clin. 2015. PMID: 25958817 Review.
Cited by
-
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems.Anticancer Agents Med Chem. 2025;25(14):978-992. doi: 10.2174/0118715206360906241223120425. Anticancer Agents Med Chem. 2025. PMID: 39901538 Review.
-
Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention.Front Immunol. 2018 Nov 30;9:2772. doi: 10.3389/fimmu.2018.02772. eCollection 2018. Front Immunol. 2018. PMID: 30555465 Free PMC article.
-
Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent 90Y-DOTA-EB-MCG.Bioconjug Chem. 2018 Jul 18;29(7):2309-2315. doi: 10.1021/acs.bioconjchem.8b00292. Epub 2018 Jun 15. Bioconjug Chem. 2018. PMID: 29865797 Free PMC article.
-
Combination Modality Using Quercetin to Enhance the Efficacy of Docetaxel in Prostate Cancer Cells.Cancers (Basel). 2023 Jan 31;15(3):902. doi: 10.3390/cancers15030902. Cancers (Basel). 2023. PMID: 36765857 Free PMC article.
-
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.Cell Commun Signal. 2019 Sep 18;17(1):120. doi: 10.1186/s12964-019-0410-y. Cell Commun Signal. 2019. PMID: 31530281 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical